ClearPoint Neuro, Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Notes Payable (Details Narrative)

Notes Payable (Details Narrative) - USD ($)		1 Months Ended	12 Months Ended
Notes Payable (Details Narrative) - USD ($)	Apr. 04, 2016	Mar. 31, 2014	Dec. 31, 2016	Dec. 31, 2015
Debt Instrument [Line Items]
Proceeds from common stock called			$ 5,800,000	$ 8,600,000
Unamortized discount			$ 2,424,457
Common stock par value (in dollars per share)			$ 0.01	$ 0.01
Loss on restructuring of debt			$ (811,909)
Private Placement (Securities Purchase Agreements) [Member] \| 12% Junior Secured Notes Payable 2014 [Member] \| Warrant [Member]
Debt Instrument [Line Items]
Number of each common stock called		0.01
Number of common stock called		27,937
Proceeds from common stock called		$ 3,725,000
Warrant exercise price (in dollars per share)		$ 70.00
Fair value		$ 413,057
Brainlab Senior Secured Note Payable [Member]
Debt Instrument [Line Items]
Stated interest rate				5.50%
Description of maturity date			Matures on December 31, 2018.
Debt face amount				$ 5,000,000
Description of payment terms			Payable in a single aggregate installment upon maturity.
Maturity date				Apr. 30, 2016
Brainlab Senior Secured Note Payable [Member] \| 2016 Securities Purchase Agreement (Patent And Technology License Agreement) [Member]
Debt Instrument [Line Items]
Debt cancelled principal amount	$ 1,000,000
Brainlab Senior Secured Note Payable [Member] \| 2016 Securities Purchase Agreement (Patent And Technology License Agreement) [Member] \| 2016 Series A Warrants [Member]
Debt Instrument [Line Items]
Number of each common stock called	0.40
Warrant exercise price (in dollars per share)	$ 16.23
Number of common shares issued	1
Brainlab Senior Secured Note Payable [Member] \| 2016 Securities Purchase Agreement (Patent And Technology License Agreement) [Member] \| 2016 Series B Warrants [Member]
Debt Instrument [Line Items]
Number of each common stock called	0.30
Warrant exercise price (in dollars per share)	$ 21.10
Number of common shares issued	1
Brainlab Senior Secured Note Payable [Member] \| 2016 Securities Purchase Agreement (Patent And Technology License Agreement) [Member] \| Common Stock [Member]
Debt Instrument [Line Items]
Common stock par value (in dollars per share)	$ 0.01
Number of common shares issued	1
Brainlab Senior Secured Note Payable [Member] \| 2016 Securities Purchase Agreement [Member]
Debt Instrument [Line Items]
Accrued interest	$ 740,000
Debt cancelled principal amount	$ 1,300,000
Number of units issued	99,310
Brainlab Senior Secured Note Payable [Member] \| 2016 Registration Rights Agreement [Member]
Debt Instrument [Line Items]
Debt face amount	$ 1,300,000
Brainlab Senior Secured Note Payable [Member] \| 2016 Registration Rights Agreement [Member] \| Minimum [Member]
Debt Instrument [Line Items]
Stated interest rate	2.00%
Brainlab Senior Secured Note Payable [Member] \| 2016 Registration Rights Agreement [Member] \| Maximum [Member]
Debt Instrument [Line Items]
Stated interest rate	10.00%
Brainlab Senior Secured Note Payable [Member] \| Private Placement (Securities Purchase Agreements) [Member]
Debt Instrument [Line Items]
Debt face amount				$ 740,000
Gain on foregoing of debt			$ 941,000
New Brainlab Note (amended and restated secured note) [Member] \| 2016 Securities Purchase Agreement [Member]
Debt Instrument [Line Items]
Debt face amount	$ 2,000,000
Description of collateral terms	Collateralized by a senior security interest in the assets of the Company.
Maturity date	Dec. 31, 2018
Loss on restructuring of debt			820,000
2014 Secured Notes [Member] \| Private Placement (Securities Purchase Agreements) [Member]
Debt Instrument [Line Items]
Debt face amount		$ 3,725,000
Maturity period		5 years
Debt frequency of periodic payment		Semi-annually
Description of collateral terms		The 2014 Secured Notes are collateralized by a security interest in the Company’s property and assets, which security interest is junior and subordinate to the security interest that collateralizes the New Brainlab note.
Unamortized discount		$ 413,057	121,985	301,531
2014 Secured Notes [Member] \| Private Placement (Securities Purchase Agreements) [Member] \| Non-Employee Directors [Member]
Debt Instrument [Line Items]
Debt face amount		1,100,000
Other offering expenses			$ 58,789	$ 166,080
2014 Secured Notes [Member] \| Private Placement (Securities Purchase Agreements) [Member] \| Placement Agents [Member]
Debt Instrument [Line Items]
Fair value		30,210
Placement agents cash commission		145,500
Other offering expenses		$ 76,186
2014 Secured Notes [Member] \| Private Placement (Securities Purchase Agreements) [Member] \| Placement Agents [Member] \| Warrant [Member]
Debt Instrument [Line Items]
Number of warrants issued to placement agent		1,818